AI/Machine Learning
Glucose monitoring startup Vively metabolises $1.6 million Seed round
Metabolic health monitoring platform Vively has raised $1.6 million in a Seed round as it rolls out its Continuous Glucose Monitoring (CGM) program to tackle pre-diabetes. The round was led by Archangel Ventures with support from Bupa Ventures, the VC arm of not-for-profit private health insurer Bupa, and others. Archangel previously led 2022’s $1.5 million… Read more »
